EGFR and cancer: Interestingly, we also found that the upregulation of phospho-AKT appeared to be an adaptive pro-survival of EGFR-mutant NSCLC cells under lysine reduction (Figure 7), which is consistent with the pro-survival role of AKT observed under other stresses in cancer cells [38,39].